Arbutus Biopharma (NASDAQ:ABUS – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Chardan ...

The clinical-stage biopharmaceutical company said its board approved a workforce reduction of 57%, bringing its employee count down to 19. It also decided to exit its corporate headquarters in ...

Marc Forth Steps Down as President and CEO to Pursue Another Opportunity; will remain on the Board of Directors – – Jost Fischer, Chairman of AEON, will assume the role of interim CEO – IRVINE, Calif.

StockNews.com assumed coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note published on Saturday. The firm issued a hold rating on the biotechnology company’s stock.

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Xeris ...

NEWARK, CA / ACCESS Newswire / March 18, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company"), a clinical-stage biopharmaceutical company pioneering the discovery and development of ...

Marc Forth is stepping down as president and CEO of Irvine-based Aeon Biopharma, a clinical-stage biopharmaceutical company, effective April 4.

Biopharmaceutical company recognized for innovation in the development of immune-modulatory therapeutic cancer vaccines –NEW YORK, March 18, ...

– Initiated analytical studies in Q4 2024 to prepare for a potential Biosimilar Biological Product Development (“BPD”) Type 2a meeting with the FDA in the second half of 2025 ...

Fintel reports that on March 27, 2025, JP Morgan initiated coverage of Mereo BioPharma Group plc - Depositary Receipt () ...

Biopharma employees reporting a positive business outlook for their companies dropped month over month but increased year ...